Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D 3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells
Diego Iglesias-Gato, Shasha Zheng, John N. Flanagan, Lan Jiang, Atsushi Kittaka, Toshiyuki Sakaki, Keiko Yamamoto, Toshimasa Itoh, Nathan K. Lebrasseur, Gunnar Norstedt, Tai C. Chen
Dive into the research topics of 'Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D 3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells'. Together they form a unique fingerprint.